Hub : Traits :

Mouth/teeth dental problems: Mouth ulcers

468 significantly associated models · 55 unique genes.

Significant Loci

#	chr	p0	p1	# assoc genes	# joint genes	best TWAS P	best SNP P	cond SNP P	% var exp	joint genes
1	1	150008790	151547253	3	1	7.6e-08	2.6e-08	5.1e-02	88	ENSA
2	1	160470756	161883083	1	1	2.0e-07	4.4e-07	1.0e+00	100	NDUFS2
3	1	196798989	198436809	1	1	2.6e-09	1.7e-08	1.1e-02	80	DENND1B
4	3	45262393	47544003	10	6	1.6e-54	2.8e-52	1.0e+00	100	CCR1 CCR3 CCR5 FYCO1
5	3	158296916	161490079	8	11	4.9e-19	7.1e-162	NaN	NaN	IFT80 IL12A KPNA4 KRT8P12 PPM1L SCHIP1 TRIM59
6	5	158501850	159005439	1	1	2.5e-09	7.5e-10	6.3e-02	91	IL12B
7	7	127878155	129284182	1	1	3.9e-10	5.8e-09	7.5e-01	100	IRF5
8	8	89923420	91465011	2	1	9.8e-08	1.5e-11	2.5e-06	51	RIPK2
9	11	94861491	96256398	1	1	2.7e-07	6.1e-07	1.0e+00	100	AP001877.1
10	16	85689653	86201589	1	1	5.1e-09	1.6e-13	1.3e-10	24	IRF8
11	17	37820992	38316776	1	1	1.4e-07	1.5e-07	1.0e+00	100	GSDMB
12	17	42774693	45796313	19	1	1.6e-11	7.7e-11	1.0e+00	100	KANSL1-AS1
13	19	4545717	5043573	1	1	9.8e-10	2.0e-10	1.0e+00	100	FEM1A
14	19	17473015	18902592	1	1	4.8e-12	1.1e-10	8.9e-01	100	IL12RB1
15	19	46157004	47589895	3	1	6.2e-22	4.4e-20	1.1e-02	92	AC007193.9
16	20	48109475	49505582	1	1	2.2e-07	5.7e-14	4.8e-08	47	CEBPB

Pleiotropic Associations

Trait	chisq ratio	# genes⁺	# genes⁺⁺	% genes⁺⁺	corr	corr P	genes
Depressed Affect (Nagel 2018)	1.73	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Depression (Nagel 2018)	0.88	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Intelligence (Savage-Jansen 2018)	0.88	2	0	0.0	0.00	1.0e+00	AP001877.1 KANSL1-AS1
Neuroticism (Nagel 2018)	2.16	2	1	2.2	0.00	1.0e+00	DENND1B KANSL1-AS1
Worry (Nagel 2018)	1.98	2	1	2.2	0.00	1.0e+00	DENND1B KANSL1-AS1
Alzheimer’s Disease (including proxy)	1.35	1	1	2.2	0.00	1.0e+00	NDUFS2
Crohns Disease (2017)	3.45	4	2	4.4	0.15	8.5e-01	AC007193.9 DENND1B GSDMB IL12B
Irritable Bowel Disease (IBD)	4.28	3	2	4.4	0.00	1.0e+00	DENND1B GSDMB IL12B
Ulcerative Colitis (UC)	4.06	3	3	6.7	0.00	1.0e+00	GSDMB IL12B IRF5
Verbal and Numeric Reasoning (VNR)	1.11	2	0	0.0	0.00	1.0e+00	AP001877.1 KANSL1-AS1
Breast Cancer	1.93	2	2	4.4	0.00	1.0e+00	CEBPB KANSL1-AS1
Ovarian Cancer	1.80	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Prostate Cancer	3.01	1	0	0.0	0.00	1.0e+00	PPM1L
Coronary Artery Disease (CAD)	1.49	1	0	0.0	0.00	1.0e+00	ENSA
Crohns Disease (2012)	2.94	3	2	4.4	0.00	1.0e+00	GSDMB IL12B KANSL1-AS1
HDL Cholesterol	1.17	1	1	2.2	0.00	1.0e+00	GSDMB
LDL Cholesterol	2.61	1	0	0.0	0.00	1.0e+00	TRIM59
Lupus	5.77	2	1	2.2	0.00	1.0e+00	IL12A IRF5
Neuroticism (2016)	2.36	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Primary Biliary Cirrhosis	14.93	10	7	15.6	-0.37	1.9e-01	DENND1B GSDMB IFT80 IL12A IRF5 KANSL1-AS1 KPNA4 PPM1L SCHIP1 TRIM59
Rheumatoid Arthritis	4.23	2	1	2.2	0.00	1.0e+00	GSDMB IRF5
Ulcerative Colitis	2.74	3	3	6.7	0.00	1.0e+00	GSDMB IL12B IRF5
Blood Eosinophil Count	2.32	9	6	13.3	-0.49	1.5e-01	AC007193.9 CCR1 DENND1B ENSA IRF5 IRF8 KANSL1-AS1 NDUFS2 PPM1L
Blood Platelet Count	0.97	9	3	6.7	0.37	3.2e-01	CEBPB ENSA GSDMB IFT80 IRF5 KANSL1-AS1 KPNA4 NDUFS2 TRIM59
Blood Red Count	2.53	8	1	2.2	0.46	1.8e-01	AC007193.9 AP001877.1 CCR1 IFT80 KANSL1-AS1 KPNA4 NDUFS2 TRIM59
Blood White Count	4.43	5	4	8.9	0.08	9.0e-01	AC007193.9 CCR5 GSDMB KANSL1-AS1 NDUFS2
Heel T-Score	1.88	9	2	4.4	0.27	3.7e-01	CEBPB FYCO1 IFT80 IL12A IL12RB1 IRF5 KANSL1-AS1 KPNA4 TRIM59
Height	0.52	6	5	11.1	0.49	3.3e-01	AP001877.1 CCR3 CCR5 ENSA IRF5 KANSL1-AS1
Waist Hip Ratio (WHR)	1.60	3	2	4.4	0.00	1.0e+00	IL12RB1 KANSL1-AS1 NDUFS2
Systolic Blood Pressure	2.79	6	5	11.1	-0.94	4.8e-05	IFT80 KANSL1-AS1 KPNA4 KRT8P12 PPM1L TRIM59
Allergy or Eczema	1.08	2	1	2.2	0.00	1.0e+00	ENSA GSDMB
Cardiovascular Disease	2.05	4	1	2.2	-0.96	2.2e-03	IFT80 KPNA4 PPM1L TRIM59
Hypothyroidism (self reported)	2.64	3	1	2.2	0.00	1.0e+00	FEM1A IL12A IRF5
Respiratory disease	4.38	1	1	2.2	0.00	1.0e+00	GSDMB
Lung FEV1/FVC ratio	1.04	4	1	2.2	-0.53	4.7e-01	ENSA GSDMB IL12RB1 KANSL1-AS1
Lung FVC	2.49	2	2	4.4	0.00	1.0e+00	ENSA KANSL1-AS1
Neuroticism	2.09	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Chronotype (morning person)	1.84	1	0	0.0	0.00	1.0e+00	KPNA4
Hair Pigment	0.14	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Tanning	0.22	1	1	2.2	0.00	1.0e+00	ENSA
Hand grip strength (left)	1.11	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Sensitivity / hurt feelings	2.26	2	1	2.2	0.00	1.0e+00	DENND1B KANSL1-AS1
Frequency of depressed mood in last 2 weeks	0.85	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Relative age of first facial hair	2.23	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Systolic blood pressure, automated reading	2.70	5	2	4.4	-0.96	7.5e-04	IFT80 KANSL1-AS1 KPNA4 PPM1L TRIM59
Vitamin and mineral supplements	1.72	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Impedance of leg (right)	1.95	5	3	6.7	-0.97	4.9e-03	AP001877.1 ENSA FYCO1 IFT80 KANSL1-AS1
Leg fat-free mass (left)	0.86	2	0	0.0	0.00	1.0e+00	ENSA FYCO1
Trunk fat percentage	0.86	3	0	0.0	0.00	1.0e+00	ENSA IL12RB1 KANSL1-AS1
Hand grip strength (right)	1.16	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Fed-up feelings	1.63	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Relative age voice broke	2.01	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Taking other prescription medications	1.47	1	0	0.0	0.00	1.0e+00	GSDMB
Age when periods started (menarche)	0.77	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Heel bone mineral density (BMD) T-score, automated (left)	1.38	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
High blood pressure	2.15	1	0	0.0	0.00	1.0e+00	TRIM59
Hayfever, allergic rhinitis or eczema	0.95	1	1	2.2	0.00	1.0e+00	GSDMB
Medication: Levothyroxine sodium	2.08	1	1	2.2	0.00	1.0e+00	FEM1A
Sitting height	1.09	3	2	4.4	0.00	1.0e+00	CCR3 ENSA KANSL1-AS1
Body mass index (BMI)	0.55	1	0	0.0	0.00	1.0e+00	DENND1B
Impedance of leg (left)	1.60	5	1	2.2	-0.98	4.3e-03	AP001877.1 ENSA FYCO1 IFT80 KANSL1-AS1
Leg predicted mass (left)	0.86	1	0	0.0	0.00	1.0e+00	ENSA
Trunk fat mass	0.60	2	0	0.0	0.00	1.0e+00	IL12RB1 KANSL1-AS1
Waist circumference	0.57	1	0	0.0	0.00	1.0e+00	IL12RB1
Nervous feelings	2.05	2	1	2.2	0.00	1.0e+00	DENND1B KANSL1-AS1
Frequency of tenseness / restlessness in last 2 weeks	2.38	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Hearing difficulty/problems with background noise	1.39	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Hair/balding pattern: Pattern 2	1.02	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Forced vital capacity (FVC)	1.83	2	2	4.4	0.00	1.0e+00	ENSA KANSL1-AS1
Heel bone mineral density (BMD) T-score, automated (right)	1.57	1	0	0.0	0.00	1.0e+00	KPNA4
Ever unenthusiastic/disinterested for a whole week	1.81	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Qualifications: None of the above	2.18	1	1	2.2	0.00	1.0e+00	AP001877.1
Mouth/teeth dental problems	5.12	6	1	2.2	-0.98	9.1e-04	CCR1 CCR3 FYCO1 IL12RB1 IRF5 KANSL1-AS1
Allergy	1.88	1	1	2.2	0.00	1.0e+00	GSDMB
Diabetes (self-reported)	2.38	1	0	0.0	0.00	1.0e+00	TRIM59
Hayfever/allergic rhinitis (self-reported)	1.71	1	0	0.0	0.00	1.0e+00	GSDMB
Neuroticism score	1.83	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Impedance of arm (right)	1.54	2	2	4.4	0.00	1.0e+00	ENSA KANSL1-AS1
Trunk fat-free mass	0.96	2	1	2.2	0.00	1.0e+00	AP001877.1 ENSA
Time employed in main current job	0.88	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Worrier / anxious feelings	1.52	3	1	2.2	0.00	1.0e+00	AP001877.1 DENND1B KANSL1-AS1
Hair/balding pattern: Pattern 3	2.06	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Number of live births	0.91	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Forced expiratory volume in 1-second (FEV1)	1.72	2	1	2.2	0.00	1.0e+00	ENSA KANSL1-AS1
Qualifications: A levels/AS levels or equivalent	1.94	2	1	2.2	0.00	1.0e+00	AP001877.1 KANSL1-AS1
Asthma	4.37	1	1	2.2	0.00	1.0e+00	GSDMB
Medication: Ibuprofen (e.g. Nurofen)	1.39	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Forced expiratory volume in 1-second (FEV1), Best measure	1.69	2	1	2.2	0.00	1.0e+00	ENSA KANSL1-AS1
Impedance of arm (left)	1.59	2	2	4.4	0.00	1.0e+00	ENSA KANSL1-AS1
Trunk predicted mass	0.97	2	1	2.2	0.00	1.0e+00	AP001877.1 ENSA
Standing height	0.48	2	1	2.2	0.00	1.0e+00	CCR5 KANSL1-AS1
Seen doctor (GP) for nerves, anxiety, tension or depression	0.77	1	0	0.0	0.00	1.0e+00	DENND1B
Hair/balding pattern: Pattern 4	3.60	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Peak expiratory flow (PEF)	1.32	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Medication: Paracetamol	1.91	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Headache pain in last month	1.82	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Hypothyroidism/myxoedema (self-reported)	2.18	1	1	2.2	0.00	1.0e+00	FEM1A
Medication: Ventolin 100micrograms inhaler	2.36	1	1	2.2	0.00	1.0e+00	GSDMB
Forced vital capacity (FVC), Best measure	1.96	2	2	4.4	0.00	1.0e+00	ENSA KANSL1-AS1
Body fat percentage	0.76	2	0	0.0	0.00	1.0e+00	ENSA IL12RB1
Leg fat percentage (right)	0.70	1	0	0.0	0.00	1.0e+00	IL12RB1
Arm fat-free mass (right)	0.91	1	0	0.0	0.00	1.0e+00	ENSA
Comparative body size at age 10	1.99	3	0	0.0	0.97	3.0e-02	IFT80 PPM1L TRIM59
Worry too long after embarrassment	1.27	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Wheeze or whistling in the chest in last year	1.44	1	1	2.2	0.00	1.0e+00	GSDMB
Number of children fathered	1.29	1	0	0.0	0.00	1.0e+00	DENND1B
Qualifications: College or University degree	2.74	4	2	4.4	-0.07	9.3e-01	AP001877.1 IFT80 IL12RB1 KANSL1-AS1
Medication for pain relief, constipation, heartburn	1.73	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Medication: Ibuprofen	1.14	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Whole body fat mass	0.53	1	0	0.0	0.00	1.0e+00	IL12RB1
Leg fat mass (right)	0.45	1	0	0.0	0.00	1.0e+00	IL12RB1
Arm predicted mass (right)	0.97	1	1	2.2	0.00	1.0e+00	ENSA
Alcohol intake frequency.	2.43	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Comparative height size at age 10	0.84	2	1	2.2	0.00	1.0e+00	IL12RB1 KANSL1-AS1
Suffer from 'nerves'	3.22	3	0	0.0	-0.26	7.4e-01	IFT80 KANSL1-AS1 TRIM59
Overall health rating	1.56	1	0	0.0	0.00	1.0e+00	TRIM59
Supplements: Vitamin C	1.40	1	0	0.0	0.00	1.0e+00	GSDMB
Hypertension (Self-reported)	1.96	1	0	0.0	0.00	1.0e+00	TRIM59
Whole body fat-free mass	0.97	2	1	2.2	0.00	1.0e+00	AP001877.1 ENSA
Leg fat-free mass (right)	1.11	4	0	0.0	0.98	2.2e-02	AP001877.1 ENSA FYCO1 IFT80
Handedness (chirality/laterality): Left-handed	1.35	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Mood swings	1.51	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Loneliness, isolation	1.20	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Friendships satisfaction	1.24	1	0	0.0	0.00	1.0e+00	AP001877.1
Qualifications: nursing, teaching	1.77	1	0	0.0	0.00	1.0e+00	AP001877.1
Asthma (self-reported)	4.42	1	1	2.2	0.00	1.0e+00	GSDMB
Osteoporosis (self-reported)	1.89	1	0	0.0	0.00	1.0e+00	CCR1
Forced expiratory volume in 1-second (FEV1), predicted percentage	1.78	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Whole body water mass	1.01	3	1	2.2	0.00	1.0e+00	AP001877.1 ENSA IFT80
Leg predicted mass (right)	1.12	4	0	0.0	0.98	2.3e-02	AP001877.1 ENSA FYCO1 IFT80
Number of self-reported non-cancer illnesses	2.67	1	0	0.0	0.00	1.0e+00	TRIM59
Average weekly champagne plus white wine intake	1.43	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Miserableness	1.47	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Guilty feelings	1.64	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Financial situation satisfaction	1.88	1	0	0.0	0.00	1.0e+00	AP001877.1
Medication: Blood pressure	0.76	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Medication: Paracetamol	1.81	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Basal metabolic rate	0.85	1	0	0.0	0.00	1.0e+00	ENSA
Leg fat percentage (left)	0.59	1	0	0.0	0.00	1.0e+00	IL12RB1
Arm fat-free mass (left)	0.91	1	0	0.0	0.00	1.0e+00	ENSA
Irritability	1.15	1	1	2.2	0.00	1.0e+00	KANSL1-AS1
Risk taking	0.90	1	0	0.0	0.00	1.0e+00	IL12RB1
Vascular/heart problems diagnosed by doctor	1.91	1	0	0.0	0.00	1.0e+00	TRIM59
Pain experienced in last month	1.17	1	0	0.0	0.00	1.0e+00	KANSL1-AS1
Impedance of whole body	1.71	5	2	4.4	-0.95	1.5e-02	AP001877.1 ENSA FYCO1 IFT80 KANSL1-AS1
Leg fat mass (left)	0.46	1	0	0.0	0.00	1.0e+00	IL12RB1
Arm predicted mass (left)	0.86	1	0	0.0	0.00	1.0e+00	ENSA

Associations by panel

study	tissue	# hits	% hits/tests	avg chisq
GTEx	Adipose Subcutaneous	10	0.286	1.6
GTEx	Adipose Visceral Omentum	8	0.393	1.7
GTEx	Adrenal Gland	5	0.343	1.6
GTEx	Artery Aorta	10	0.336	1.6
GTEx	Artery Coronary	9	0.761	1.8
GTEx	Artery Tibial	5	0.133	1.5
GTEx	Brain Caudate basal ganglia	4	0.435	1.6
GTEx	Brain Cerebellar Hemisphere	6	0.403	1.6
GTEx	Brain Cerebellum	6	0.303	1.6
GTEx	Brain Cortex	9	0.870	1.8
GTEx	Brain Frontal Cortex BA9	6	0.649	1.8
GTEx	Brain Hippocampus	5	0.954	1.9
GTEx	Brain Hypothalamus	4	0.678	1.9
GTEx	Brain Nucleus accumbens basal ganglia	6	0.694	1.7
GTEx	Brain Putamen basal ganglia	5	0.801	1.8
GTEx	Breast Mammary Tissue	7	0.355	1.7
GTEx	Breast Mammary Tissue (Male)	7	0.587	1.8
GTEx	Breast Mammary Tissue (Female)	6	0.365	1.7
GTEx	Cells EBV-transformed lymphocytes	7	0.492	1.7
GTEx	Cells Transformed fibroblasts	10	0.238	1.6
GTEx	Colon Sigmoid	7	0.479	1.7
GTEx	Colon Transverse	10	0.484	1.7
GTEx	Esophagus Gastroesophageal Junction	8	0.554	1.7
GTEx	Esophagus Mucosa	12	0.361	1.6
GTEx	Esophagus Muscularis	13	0.402	1.6
GTEx	Heart Atrial Appendage	7	0.443	1.7
GTEx	Heart Left Ventricle	6	0.392	1.6
GTEx	Liver	5	0.697	1.8
GTEx	Lung	10	0.348	1.6
GTEx	Muscle Skeletal	7	0.242	1.6
GTEx	Nerve Tibial	9	0.208	1.6
GTEx	Ovary	6	0.661	1.8
GTEx	Pancreas	7	0.429	1.7
GTEx	Pituitary	4	0.359	1.7
GTEx	Prostate	4	0.479	1.7
GTEx	Skin Not Sun Exposed Suprapubic	8	0.325	1.7
GTEx	Skin Sun Exposed Lower leg	11	0.302	1.5
GTEx	Small Intestine Terminal Ileum	4	0.868	1.9
GTEx	Spleen	7	0.496	1.8
GTEx	Stomach	7	0.481	1.6
GTEx	Testis	11	0.349	1.6
GTEx	Thyroid	10	0.250	1.6
GTEx	Uterus	6	1.058	2.0
GTEx	Vagina	4	0.630	1.7
GTEx	Whole Blood	7	0.351	1.8
METSIM	Adipose	7	0.152	1.5
NTR	Blood	7	0.291	1.8
ROSMAP	Brain Pre-frontal Cortex	0	0.000	1.4
YFS	Blood	5	0.108	1.5
CommonMind	Brain Pre-frontal Cortex	5	0.093	1.5
The Cancer Genome Atlas	Bladder Urothelial Carcinoma	4	0.242	1.6
The Cancer Genome Atlas	Breast Invasive Carcinoma	7	0.159	1.5
The Cancer Genome Atlas	Cervical Squamous Cell Carcinoma	3	0.273	1.5
The Cancer Genome Atlas	Colon Adenocarcinoma	4	0.194	1.5
The Cancer Genome Atlas	Esophageal Carcinoma	2	0.292	1.5
The Cancer Genome Atlas	Glioblastoma Multiforme	5	0.489	1.8
The Cancer Genome Atlas	Head and Neck Squamous Cell Carcinoma	5	0.184	1.5
The Cancer Genome Atlas	Kidney Renal Clear Cell Carcinoma	8	0.195	1.5
The Cancer Genome Atlas	Kidney Renal Papillary Cell Carcinoma	5	0.244	1.5
The Cancer Genome Atlas	Brain Lower Grade Glioma	8	0.186	1.5
The Cancer Genome Atlas	Liver Hepatocellular Carcinoma	3	0.271	1.6
The Cancer Genome Atlas	Lung Adenocarcinoma	8	0.272	1.5
The Cancer Genome Atlas	Lung Squamous Cell Carcinoma	7	0.279	1.6
The Cancer Genome Atlas	Ovarian Serous Cystadenocarcinoma	6	0.377	1.6
The Cancer Genome Atlas	Pancreatic Adenocarcinoma	5	0.301	1.6
The Cancer Genome Atlas	Pheochromocytoma and Paraganglioma	4	0.301	1.6
The Cancer Genome Atlas	Prostate Adenocarcinoma	12	0.260	1.5
The Cancer Genome Atlas	Rectum Adenocarcinoma	4	0.579	2.0
The Cancer Genome Atlas	Soft Tissue Sarcoma	1	0.094	1.5
The Cancer Genome Atlas	Skin Cutaneous Melanoma	1	0.187	1.6
The Cancer Genome Atlas	Stomach Adenocarcinoma	2	0.119	1.5
The Cancer Genome Atlas	Testicular Germ Cell Tumors	1	0.078	1.5
The Cancer Genome Atlas	Thyroid Carcinoma	10	0.194	1.5
The Cancer Genome Atlas	Uterine Corpus Endometrial Carcinoma	4	0.787	1.8